Erleada is used to treat prostate cancer that has spread to other parts of the body (metastatic) and still responds to treatments that lower testosterone. It is also used for non-metastatic castration-resistant prostate cancer, where the cancer has not spread but no longer responds to treatments that lower testosterone.